store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Deferitazole (FBS 0701) 是一种新型且具有口服活性、选择性和高亲和力的铁螯合剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 910 | 现货 | ||
5 mg | ¥ 2,230 | 现货 | ||
10 mg | ¥ 3,360 | 现货 | ||
25 mg | ¥ 5,480 | 现货 | ||
50 mg | ¥ 7,680 | 现货 |
产品描述 | Deferitazole (FBS 0701) is a novel and orally active, selective and high affinity iron chelator. |
体外活性 | Deferitazole (FBS0701) displays a high affinity and selectivity for iron(III) as demonstrated by the log β2 = 33.39 ± 0.03 and the pFe(3+) value of 22.3. Two equilibrating isomeric forms of the iron(III) complex exist under biological conditions. Deferitazole also binds the trivalent metals Al(III) and La(III) with high affinity; log β2 values, 26.68 and 21.55 respectively. The affinity of Deferitazole for divalent cations is somewhat lower, with the exception of Cu(II) which possesses a log β2 value of 25.5; Deferitazole scavenges iron from labile sources such as citrate and albumin with efficiencies comparable with those of other therapeutic iron chelators, including deferasirox, deferiprone and desferrioxamine. The Fe(III)(Deferitazole)2 is stable under physiological conditions and does not redox cycle. The high affinity of Deferitazole for iron(III) renders it unlikely that this chelator will lead to the redistribution of iron and consequently Deferitazole shows considerable promise as a therapeutic iron(III) chelator.[1] |
别名 | SPD602, FBS 0701, SPD-602, FBS0701, FBS-0701, SPD 602 |
分子量 | 399.46 |
分子式 | C18H25NO7S |
CAS No. | 945635-15-4 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (125.17 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5034 mL | 12.5169 mL | 25.0338 mL | 62.5845 mL |
5 mM | 0.5007 mL | 2.5034 mL | 5.0068 mL | 12.5169 mL | |
10 mM | 0.2503 mL | 1.2517 mL | 2.5034 mL | 6.2584 mL | |
20 mM | 0.1252 mL | 0.6258 mL | 1.2517 mL | 3.1292 mL | |
50 mM | 0.0501 mL | 0.2503 mL | 0.5007 mL | 1.2517 mL | |
100 mM | 0.025 mL | 0.1252 mL | 0.2503 mL | 0.6258 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Deferitazole 945635-15-4 Others SPD602 FBS 0701 SPD-602 FBS0701 FBS-0701 SPD 602 Inhibitor inhibitor inhibit